Rituximab and Pembrolizumab With or Without Lenalidomide in Treating Patients With Relapsed Follicular Lymphoma and Diffuse Large B-Cell Lymphoma (clinicaltrials.gov) - Oct 23, 2026 - P2 | N=53 | Active, not recruiting | Sponsor: M.D. Anderson Cancer Center | Trial completion date: Apr 2026 ➔ Apr 2030
Trial completion date • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Follicular Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin's Lymphoma • Oncology
|